File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437)
Title | IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437) |
---|---|
Authors | |
Issue Date | 2022 |
Citation | The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology, v. 77 n. S1, p. S872-873 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/318292 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bourgeois, S | - |
dc.contributor.author | Lim, Y-S | - |
dc.contributor.author | Gane, EJ | - |
dc.contributor.author | Lee, HW | - |
dc.contributor.author | Cheng, W | - |
dc.contributor.author | Heo, J | - |
dc.contributor.author | Kim, W | - |
dc.contributor.author | Buti, M | - |
dc.contributor.author | Thompson, A | - |
dc.contributor.author | Matthews, G | - |
dc.contributor.author | Janczewska, E | - |
dc.contributor.author | Ryder, S | - |
dc.contributor.author | Andrade, RJ | - |
dc.contributor.author | Yuan, Y | - |
dc.contributor.author | Benlahrech, A | - |
dc.contributor.author | Wustner, J | - |
dc.contributor.author | Dorrell, L | - |
dc.contributor.author | Yuen, RMF | - |
dc.date.accessioned | 2022-10-07T10:36:11Z | - |
dc.date.available | 2022-10-07T10:36:11Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology, v. 77 n. S1, p. S872-873 | - |
dc.identifier.uri | http://hdl.handle.net/10722/318292 | - |
dc.language | eng | - |
dc.relation.ispartof | The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology | - |
dc.title | IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437) | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Yuen, RMF: mfyuen@hku.hk | - |
dc.identifier.authority | Yuen, RMF=rp00479 | - |
dc.identifier.hkuros | 337768 | - |
dc.identifier.volume | 77 | - |
dc.identifier.issue | S1 | - |
dc.identifier.spage | S872 | - |
dc.identifier.epage | 873 | - |